We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDER Increases Enforcement With Clinical Trial Warning Letters
CDER Increases Enforcement With Clinical Trial Warning Letters
September 4, 2009
CDER’s Division of Scientific Investigations (DSI) has more than doubled the number of clinical trial warning letters it sent so far this fiscal year, compared with those sent in fiscal 2006.